TCG Lifesciences Expands Pharmaceutical, Biotechnology Research Initiatives with CAS’ SciFinder®
04, 2011 -
Leading India-based contract research organization signs three-year contract for the premier chemical and scientific research tool
Kolkata, India (April 4, 2011)- Chemical Abstracts Service (CAS), the world's authority for chemical information, announced today that TCG Lifesciences Limited, a leading contract research services and informatics company based in India, has signed a three-year contract to provide its scientists and researchers with unlimited access to SciFinder®. SciFinderwill help TCG Lifesciences grow its position as a contract research organization that provides a new paradigm of cutting edge drug discovery and development platform in the competitive and fast growing Indian pharmaceutical research space.
We have had a relationship with CAS for a long time, hence when we were required to select an enterprise-wide research platform for our R&D teams, SciFinder was the clear choice, given its reliable, high-quality content and advanced reaction planning tools. Our scientists now have on-demand access to the largest collection of small molecules and related information, including references to millions of peer-reviewed research papers and patents. SciFinder gives our researchers the insight they need to produce the flagship laboratory data for which we are known,” said Dr. Sourav Basu, Associate Vice-President of TCG Lifesciences.
SciFinder, the world’s leading research and discovery tool, will offer TCG Lifesciences teams a variety of powerful research and analysis options, including Markush searching for retrieving additional patents for substances that are claimed in generic terms, and the recently-announced SciPlanner™, an interactive reaction planning workspace especially valuable for pharmaceutical and biotechnology research.
SciFinder’s comprehensive and current content, sophisticated analysis and collaboration capabilities, and demonstrated results inside the lab and out have made it the preferred source of chemical information for scientists around the globe. Its streamlined navigation and intuitive interface integrated with CAS’ trusted content gives researchers confidence in the quality of their work.
“CAS is committed to providing the most complete collection of reliable chemical information needed by chemists and other researchers to drive innovation,” said Robert J. Massie, president of CAS. “We look forward to supporting TCG Lifesciences’ work in the arena of drug discovery and development, as they continue to enhance and make potential life-saving advancements through their R&D efforts.”
SciFinder is the leading research tool for chemists and researchers, providing the essential content and proven results scientists need to increase productivity and make faster breakthroughs. The intuitive, award-winning application offers instant access to the most comprehensive collection of chemical substance and reaction information, including CAS REGISTRYSM— the gold standard of chemical substance collections. Fortune 500 corporations, more than 1,800 universities, and major government agencies around the world rely on SciFinder to fuel R&D initiatives and foster innovation.